{"filing":{"accession_number":"0001193125-26-254622","cik":"0001088856","ticker":"CORT","company_name":"CORCEPT THERAPEUTICS INC","form":"8-K","filing_date":"2026-06-03","report_date":null,"primary_document":"d103585d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526254622/d103585d8k.htm"},"events":[{"id":7138,"run_id":6263,"accession_number":"0001193125-26-254622","anchor_item_number":"8.01","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.92,"summary":"This disclosure concerns a material qui tam lawsuit filed by a former employee against Corcept in February 2017 alleging improper sales and promotion practices related to Korlym®, with DOJ investigation (subpoena issued November 2021) and an amended complaint served June 2, 2026. The DOJ's declination to intervene does not eliminate the litigation risk; the Relator proceeds independently. This is a material regulatory/litigation matter affecting the company's legal exposure and product reputation.","company_name":"CORCEPT THERAPEUTICS INC","ticker":"CORT","filing_date":"2026-06-03","submitted_at":null,"items":[{"id":3939,"accession_number":"0001193125-26-254622","item_number":"8.01","item_title":null,"event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.92,"reasoning":"This disclosure concerns a material qui tam lawsuit filed by a former employee against Corcept in February 2017 alleging improper sales and promotion practices related to Korlym®, with DOJ investigation (subpoena issued November 2021) and an amended complaint served June 2, 2026. The DOJ's declination to intervene does not eliminate the litigation risk; the Relator proceeds independently. This is a material regulatory/litigation matter affecting the company's legal exposure and product reputation.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:22:06.977042+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3939,"accession_number":"0001193125-26-254622","item_number":"8.01","item_title":null,"event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.92,"reasoning":"This disclosure concerns a material qui tam lawsuit filed by a former employee against Corcept in February 2017 alleging improper sales and promotion practices related to Korlym®, with DOJ investigation (subpoena issued November 2021) and an amended complaint served June 2, 2026. The DOJ's declination to intervene does not eliminate the litigation risk; the Relator proceeds independently. This is a material regulatory/litigation matter affecting the company's legal exposure and product reputation.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-04T02:22:06.977042+00:00","company_name":"CORCEPT THERAPEUTICS INC","ticker":"CORT","filing_date":"2026-06-03"}]}